Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families

Fig. 2

The effect of Rifampicin on M. tuberculosis Uganda II, Beijing and Delhi/CAS. Panel B1, aerobic conditions. control b, Beijing with no drug; control c, Delhi/CAS with no drug; control u, Uganda II with no drug; ce0.12 μg/ml, Delhi/CAS at 1x MIC; ue1 μg/ml, Uganda II at 1x MIC; be0.12 μg/ml, Beijing at 1x MIC; ce0.24 μg/ml, Delhi/CAS at 2x MIC; ue2 μg/ml, Uganda II at 2x MIC; be0.24 μg/ml, Beijing at 2x MIC; ce0.6 μg/ml, Delhi/CAS at 5x MIC; ue5 μg/ml, Uganda II at 5x MIC; be0.6 μg/ml, Beijing at 5x MIC. Panel B2, same as in Panel B1 but under oxygen-depleted conditions

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us